ライフサイエンスコーパス: squamous cell

1 arms for either histology (adenocarcinoma or squamous cell).

2 ost-progression tumour samples, we found one squamous cell and two small-cell transformations.

3 prognostic value for resected head and neck squamous cell cancer (HNSCC).

4 rd of care in locally advanced head and neck squamous cell cancer (LAHNSCC).

5 ment for Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Cancer (LSCC) and the ERK2-VTX11e treatmen

6 ly when applied to HPV-related oropharyngeal squamous cell cancer (OPSCC), leading to calls for a new

7 iopsy samples of 19 patients with esophageal squamous cell cancer and 9 sex- and age-matched patients

8 esistant colorectal cancer and head and neck squamous cell cancer cell lines and in tumors from color

9 10 was compared with uptake in head and neck squamous cell cancer FaDu (intermediate EpCAM) and promy

10 ed by its pathogenic mutations in esophageal squamous cell cancers (SCCs).

11 nce the effect of chemotherapy on esophageal squamous cell cancers.

12 treatment of locally advanced head and neck squamous cell cancers.

13 multiple genes that are mutated in cutaneous squamous cell cancers.

14 All 11 patients developed a squamous cell carcinoma (14 malignancies), and 1 patient

15 re being treated for basal cell carcinoma or squamous cell carcinoma (cases) and 100 individuals who

16 Perineural invasion (PNI) in cutaneous squamous cell carcinoma (CSCC) has been associated with

17 nsformation of normal epidermis to cutaneous squamous cell carcinoma (cSCC) is causally linked to alt

18 Cutaneous squamous cell carcinoma (cSCC) is one of the most common

19 Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metast

20 Cutaneous squamous cell carcinoma (cSCC) is the second most common

21 ified genetic loci associated with cutaneous squamous cell carcinoma (cSCC) risk, but single-nucleoti

22 have a 100-fold increased risk of cutaneous squamous cell carcinoma (cSCC).

23 s with inoperable locally advanced cutaneous squamous cell carcinoma (cSCC).

24 -wide association study (GWAS) on esophageal squamous cell carcinoma (ESCC) in Han Chinese, we conduc

25 issues removed from patients with esophageal squamous cell carcinoma (ESCC) with poor prognosis, and

26 ophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), although evidence is lim

27 h enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the deadliest of a

28 have efficacy in EGFR-amplified oesophageal squamous cell carcinoma (ESCC), but may become quickly i

29 e to chronic fungal infection and esophageal squamous cell carcinoma (ESCC).

30 chemoresistance in patients with esophageal squamous cell carcinoma (ESCC).

31 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced

32 Head and neck squamous cell carcinoma (HNSCC) accounts for nearly 90%

33 cetuximab in locally advanced head and neck squamous cell carcinoma (HNSCC) and biomarkers that pred

34 potential relationship between head and neck squamous cell carcinoma (HNSCC) and microbial dysbiosis,

35 is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) and other cancers.

36 to examine whether staging of head and neck squamous cell carcinoma (HNSCC) by upfront (18)F-FDG PET

37 panel of 49 established human head and neck squamous cell carcinoma (HNSCC) cell lines and report th

38 l Cell Lung Cancer (NSCLC) and Head and Neck Squamous Cell Carcinoma (HNSCC) cell lines and was due t

39 phenotypes in patient-derived head and neck squamous cell carcinoma (HNSCC) cells in vitro and in vi

40 papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) have better responses to

41 Head and neck squamous cell carcinoma (HNSCC) includes epithelial canc

42 Head and neck squamous cell carcinoma (HNSCC) is the sixth most common

43 Head and neck squamous cell carcinoma (HNSCC) patients have a poor pro

44 ely 6,000 single cells from 18 head and neck squamous cell carcinoma (HNSCC) patients, including five

45 apillomavirus-related (HPV(+)) head and neck squamous cell carcinoma (HNSCC) samples.

46 e cell growth of p53-deficient head and neck squamous cell carcinoma (HNSCC) UM-SCC-1 cells both in i

47 ne and metabolic phenotypes in head and neck squamous cell carcinoma (HNSCC) were assessed and change

48 nt-resistant head and neck tumors, including squamous cell carcinoma (HNSCC), adenoid cystic carcinom

49 clinically validated target in head and neck squamous cell carcinoma (HNSCC), where EGFR-blocking ant

50 ectively inhibit the growth of head and neck squamous cell carcinoma (HNSCC).

51 the survival of patients with head and neck squamous cell carcinoma (HNSCC).

52 h the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC).

53 various cancers, including the head and neck squamous cell carcinoma (HNSCC).

54 us (HPV) detection and risk of head and neck squamous cell carcinoma (HNSCC).

55 sion is a hallmark of advanced head and neck squamous cell carcinoma (HNSCC).

56 defective molecular switch in head and neck squamous cell carcinoma (HNSCC).

57 gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cancer cells were studi

58 eck in locoregionally advanced head-and-neck squamous cell carcinoma (LAHNSCC) after concurrent chemo

59 iling to analyze TLS formation in human lung squamous cell carcinoma (LSCC) and in an experimental mo

60 specific copy number gain (CNG) in both lung squamous cell carcinoma (LSCC) and ovarian serous carcin

61 TF), a measure of tumor invasiveness of lung squamous cell carcinoma (LSCC).

62 ibe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both

63 between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), two main lung cancer sub

64 a, classified as adenocarcinoma (n = 4,036), squamous cell carcinoma (n = 1,998), small cell carcinom

65 patients with nonoropharyngeal head and neck squamous cell carcinoma (non-OP HNSCC).

66 patients with nonoropharyngeal head and neck squamous cell carcinoma (non-OP HNSCC).

67 Adequate resection of oral cavity squamous cell carcinoma (OCSCC) means complete tumor rem

68 n papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) has been reported predom

69 The incidence of HPV-related oropharyngeal squamous cell carcinoma (OPSCC) has increased more than

70 papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) has shown resistance to

71 A rising incidence of oropharyngeal squamous cell carcinoma (OPSCC) incidence has occurred t

72 papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) is disproportionately hi

73 Purpose Treatment of oropharyngeal squamous cell carcinoma (OPSCC) is evolving toward risk-

74 apillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is treatment-responsive.

75 and a separate dataset of HPV+ oropharyngeal squamous cell carcinoma (OPSCC) samples to identify diff

76 deline on radiation therapy in oropharyngeal squamous cell carcinoma (OPSCC) that was determined to b

77 Human oral squamous cell carcinoma (OSCC) constitutes an inflammato

78 Most cases of oral squamous cell carcinoma (OSCC) develop from visible oral

79 FA patients develop oral squamous cell carcinoma (OSCC) earlier and more frequent

80 miR-211 expression in human oral squamous cell carcinoma (OSCC) has been implicated in po

81 Oral squamous cell carcinoma (OSCC) is the most common cancer

82 ogene, ROS1, as an important driver for oral squamous cell carcinoma (OSCC) metastasis.

83 Oral squamous cell carcinoma (OSCC) patients generally have a

84 ssible association between bacteria and oral squamous cell carcinoma (OSCC) remain inconclusive, larg

85 The most common form of oral cancer is oral squamous cell carcinoma (OSCC).

86 ors with stage I adenocarcinoma (P<0.003) or squamous cell carcinoma (P=0.023) in the TCGA data set.

87 Malignant tumors included melanoma (12%), squamous cell carcinoma (SCC) (9%), lymphoma (7%), and o

88 uded 53 patients with a history of cutaneous squamous cell carcinoma (SCC) after a first kidney trans

89 ic immunosuppression promotes nonmelanocytic squamous cell carcinoma (SCC) after kidney transplantati

90 ng keratinocyte cancers, including cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (

91 Here we document TCF7L1 upregulation in skin squamous cell carcinoma (SCC) and demonstrate that TCF7L

92 alignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left u

93 It is postulated to increase the risk of squamous cell carcinoma (SCC) and other skin cancers in

94 ends in the risk of posttransplant cutaneous squamous cell carcinoma (SCC) are few and appear contrad

95 signaling mediators, but their functions in squamous cell carcinoma (SCC) are unclear.

96 Here we demonstrate for the first time that squamous cell carcinoma (SCC) EVs were enriched with the

97 fferentiating basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) from healthy tissue.

98 bution of voriconazole to the development of squamous cell carcinoma (SCC) in lung transplant recipie

99 ing to detect basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in Mohs micrographic surge

100 d incidence of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) in QSkin, a prospective st

101 lta T cells protect against the formation of squamous cell carcinoma (SCC) in several models.

102 Anal squamous cell carcinoma (SCC) is associated with both hu

103 ients (4.4%) had a partial response; one had squamous cell carcinoma (SCC) of the anus and one had SC

104 to urinary arsenic concentration and risk of squamous cell carcinoma (SCC) of the skin in a U.S. popu

105 18)F-FDG phosphorylation rate were higher in squamous cell carcinoma (SCC) than in adenocarcinoma (AC

106 Here, we report in a murine model of skin squamous cell carcinoma (SCC) that nuclear FAK regulates

107 ching of KRAS+ lung adenocarcinomas (ADC) to squamous cell carcinoma (SCC) through deletion of Lkb1 (

108 The age-standardized incidence rate of squamous cell carcinoma (SCC) was highest among black pe

109 ophagus (BE), columnar cell metaplasia (CM), squamous cell carcinoma (SCC), and squamous epithelium (

110 s), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are the most common cance

111 s), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are the most common cance

112 rs for posttransplant skin cancer, including squamous cell carcinoma (SCC), melanoma (MM), and Merkel

113 Lung squamous cell carcinoma (SCC), strongly associated with

114 of tumor-infiltrating T lymphocytes (TIL) in squamous cell carcinoma (SCC), using a systems biologic

115 n lung adenocarcinoma (LUAD) but not in lung squamous cell carcinoma (SCC).

116 ), defined as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

117 r outcomes in many human tumor types such as squamous cell carcinoma (SCC).

118 s) are found in many cancer types, including squamous cell carcinoma (SCC).

119 A)-induced hamster cheek pouch model of oral squamous cell carcinoma (SCC).

120 Adenocarcinoma (ADC) and squamous cell carcinoma (SqCC) are the two predominant s

121 denocarcinoma (AD) project and 504 from TCGA squamous cell carcinoma (SQCC) project-were classified u

122 surgical treatment modalities for subungual squamous cell carcinoma (SUSCC) without bone invasion ne

123 prised a mixed papilloma/well-differentiated squamous cell carcinoma (wdSCC), exhibiting p53 loss, in

124 patients with non-squamous cell carcinoma or squamous cell carcinoma (without positive markers, eg, E

125 letion alleles is 50% in 143 genotyped oral squamous cell carcinoma -Taiwan samples (27A3B (-/-):89A

126 Squamous cell carcinoma affecting the periocular region

127 zard ratios across subgroups, including both squamous cell carcinoma and adenocarcinoma, both cN0 and

128 because it contains two main types, namely, squamous cell carcinoma and adenocarcinoma.

129 sive phenotypes in lung adenocarcinoma, lung squamous cell carcinoma and breast carcinoma cancer cell

130 The effects were stronger for squamous cell carcinoma and ever smokers for the "fruits

131 epidermal development, psoriasis, cutaneous squamous cell carcinoma and re-epithelisation are highli

132 The most common aetiology was squamous cell carcinoma and the majority of cases (30%)

133 Squamous cell carcinoma antigen (SCCA) is a good specifi

134 d its capability in quantitative analysis of squamous cell carcinoma antigen in human serum with reco

135 ak current variation to the concentration of squamous cell carcinoma antigen in the range of 0.001-0.

136 volved in the progression of transition zone squamous cell carcinoma are poorly understood, hence rep

137 Basal and squamous cell carcinoma are the most common types of can

138 The aim of this article is to describe oral squamous cell carcinoma as it appears in different imagi

139 ith histologically verified primary head and squamous cell carcinoma at Odense University Hospital fr

140 in the pharyngeal mucosal space (n=16) with squamous cell carcinoma being the most common pathology.

141 tients treated by chemoradiotherapy for anal squamous cell carcinoma between October 2007 and October

142 ession in human breast, lung, and esophageal squamous cell carcinoma cancer xenografts.

143 We show here that in both squamous cell carcinoma cells and melanoma tumor cells,

144 against naturally HPV-infected head and neck squamous cell carcinoma cells using IFN-gamma ELISPOT an

145 Here, using mouse squamous cell carcinoma cells, we report a completely ne

146 GFR with GFP by genome-editing of human oral squamous cell carcinoma cells, which were used to examin

147 nd, like JunB, it was downregulated in human squamous cell carcinoma cells.

148 ted with CD44, HAS3, and ABCC1 expression in squamous cell carcinoma datasets and p63-HA pathway is a

149 ons on the cellular and molecular origins of squamous cell carcinoma due to oncogenic mutations in Ra

150 But the biological effect of SDT on oral squamous cell carcinoma has not been studied.

151 n exposure, IL-6 promoter variants, and lung squamous cell carcinoma in former uranium miners.

152 lopment of UV irradiation-mediated cutaneous squamous cell carcinoma in mice.

153 ential therapeutic targets for prevention of squamous cell carcinoma in patients with Kindler syndrom

154 Squamous cell carcinoma in the head and neck (HNSCC) is

155 Oesophageal squamous cell carcinoma is a deadly disease where system

156 Esophageal squamous cell carcinoma is a major histological type of

157 y genomic studies in other cancer types.Oral squamous cell carcinoma is a prevalent malignancy in Tai

158 Oral squamous cell carcinoma is a prominent cancer worldwide,

159 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.

160 randomized trials on secondary prevention of squamous cell carcinoma observed a reduction in cumulati

161 ffect radiotherapy response and prognosis of squamous cell carcinoma of oropharynx (SCCOP).

162 Squamous cell carcinoma of the anal canal (SCCA) is a ra

163 Purpose Squamous cell carcinoma of the anal canal (SCCAC) is cha

164 Purpose Squamous cell carcinoma of the anal canal (SCCAC) is cha

165 In patients with squamous cell carcinoma of the anus (SCCA), lymph node p

166 se after chemoradiotherapy for patients with squamous cell carcinoma of the anus is 26 weeks from sta

167 the quality of outcome reporting in RCTs of squamous cell carcinoma of the anus is inconsistent.

168 h newly diagnosed, histologically confirmed, squamous cell carcinoma of the anus without metastatic d

169 ) of radical chemoradiation for treatment of squamous cell carcinoma of the anus.

170 hemoradiation for treatment of patients with squamous cell carcinoma of the anus.

171 Pain is often one of the first signs of squamous cell carcinoma of the head and neck (HNSCC).

172 chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).

173 ucleus enhanced its interaction with PCNA in squamous cell carcinoma of the head and neck (SCCHN) cel

174 logically confirmed recurrent and metastatic squamous cell carcinoma of the head and neck after disea

175 ositol 3-kinase (PI3K) pathway activation in squamous cell carcinoma of the head and neck contributes

176 platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck have few tr

177 Patients with recurrent or metastatic squamous cell carcinoma of the head and neck have few tr

178 ial in patients with recurrent or metastatic squamous cell carcinoma of the head and neck who progres

179 titumour activity in recurrent or metastatic squamous cell carcinoma of the head and neck, supporting

180 fe for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, these data

181 platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck.

182 platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck.

183 ebo in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

184 d in 2004 to 2012 with AJCC stage III to IVB squamous cell carcinoma of the oral cavity, oropharynx,

185 had to include patients with non-metastatic squamous cell carcinoma of the oral cavity, oropharynx,

186 .5%), 37 basal cell carcinomas (1.9%), and 1 squamous cell carcinoma or Bowen disease (0.1%).

187 g first-line treatment for patients with non-squamous cell carcinoma or squamous cell carcinoma (with

188 nic mouse model of breast cancer and in oral squamous cell carcinoma patients, tumor development was

189 was more apparent in adenocarcinoma than in squamous cell carcinoma patients.

190 rofile in recurrent/metastatic head and neck squamous cell carcinoma previously treated with platinum

191 ments for recurrent/metastatic head and neck squamous cell carcinoma refractory to platinum and cetux

192 determinants of susceptibility to cutaneous squamous cell carcinoma remain largely unknown.

193 Cutaneous squamous cell carcinoma represents the second most commo

194 Development of cervical squamous cell carcinoma requires increased expression of

195 thway; SNPs at these loci appear to modulate squamous cell carcinoma risk independently of the pigmen

196 from the 1000 Genomes Project and esophageal squamous cell carcinoma samples show that seeksv has hig

197 abilized DeltaNp63alpha to enhance epidermal squamous cell carcinoma spheroid formation, invasion, an

198 illary urothelial carcinoma, small cell, and squamous cell carcinoma subtypes of invasive bladder can

199 However, the mechanisms underlying squamous cell carcinoma susceptibility are unclear.

200 hat SNP309G allele actually protects against squamous cell carcinoma susceptibility.

201 was associated with a nonlinear reduction in squamous cell carcinoma that became attenuated as consum

202 tion germline polymorphism in Taiwanese oral squamous cell carcinoma that impacts expression of APOBE

203 of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.

204 In mice bearing esophageal squamous cell carcinoma tumors, to estimate uptake (K),

205 Methods Adult patients with oral cavity squamous cell carcinoma undergoing upfront surgical rese

206 with subgroup analyses by histological type (squamous cell carcinoma vs adenocarcinoma) and type of n

207 and in the prestyloid parapharyngeal space, squamous cell carcinoma were the most common lesions, re

208 t in non-Hispanic whites, whereas esophageal squamous cell carcinoma with risk factors of tobacco and

209 dependence on the required imaging label in squamous cell carcinoma xenografts.

210 borrheic keratosis) or mutant p53 (cutaneous squamous cell carcinoma) appears to dictate whether a le

211 ophageal cancer (84.7% adenocarcinoma, 15.2% squamous cell carcinoma), 335 (9.3%) were treated with A

212 ted, 287 (62.8%) were BCCs, 106 (23.2%) were squamous cell carcinoma, 39 (8.5%) were lichen planus-li

213 eal adenocarcinomas, 323 cases of esophageal squamous cell carcinoma, 698 cases of gastric cardia ade

214 increase was seen in Bowen disease, invasive squamous cell carcinoma, and a superficial type of basal

215 monstrates PD-L1 detection in NSCLC, breast, squamous cell carcinoma, and melanoma.

216 in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the mo

217 In addition to esophageal squamous cell carcinoma, cancers of the small bowel, pan

218 dvantage on normal and neoplastic (cutaneous squamous cell carcinoma, cSCC) human epidermal cells.

219 Critically, in head and neck squamous cell carcinoma, Fxr1 overexpression correlates

220 lanoma skin cancers, in particular cutaneous squamous cell carcinoma, have the highest standardized i

221 he absence of p53, Nanog induces spontaneous squamous cell carcinoma, identifying a novel role of Nan

222 sophageal adenocarcinoma, but not esophageal squamous cell carcinoma, was associated with reduced eso

223 man papilloma virus-associated oropharyngeal squamous cell carcinoma, we hypothesized that adding cet

224 e aspiration from the mass was suggestive of squamous cell carcinoma, which was confirmed on immunohi

225 tudy, we determined that human head and neck squamous cell carcinoma-derived HSC-3 cells contain a su

226 Squamous cell carcinoma-related oncogene (SCCRO)/DCUN1D1

227 SCCRO (squamous cell carcinoma-related oncogene; also known as

228 ctinic keratosis is a precursor to cutaneous squamous cell carcinoma.

229 of Tgfbr2-deficient invasive transition zone squamous cell carcinoma.

230 ochemistry in 96 patients with head and neck squamous cell carcinoma.

231 poor prognosis in melanoma and head and neck squamous cell carcinoma.

232 r smokers and in participants diagnosed with squamous cell carcinoma.

233 rom the HF junctional zone and predispose to squamous cell carcinoma.

234 vival of five cancers, such as head and neck squamous cell carcinoma.

235 keratinocytes, the cell-type susceptible to squamous cell carcinoma.

236 prostate cancer, urothelial cancer, and skin squamous cell carcinoma.

237 associated with skin keratosis and cutaneous squamous cell carcinoma.

238 ll proportion of the disease can progress to squamous cell carcinoma.

239 was not observed in patients with esophageal squamous cell carcinoma.

240 h T1/T2 clinically node-negative oral cavity squamous cell carcinoma.

241 of miR-203-induced transcriptomic changes in squamous cell carcinoma.

242 ity, photosensitivity, and increased risk of squamous cell carcinoma.

243 harbor high-grade dysplasia or even invasive squamous cell carcinoma.

244 candidiasis, hypothyroidism, and esophageal squamous cell carcinoma.

245 up-regulated in human actinic keratosis and squamous cell carcinoma.

246 t to CHCT/MRI in patients with head and neck squamous cell carcinoma.

247 ma, esophageal adenocarcinoma, or esophageal squamous cell carcinoma.Among older American adults, bot

248 half of the world's 500,000 new oesophageal squamous-cell carcinoma (ESCC) cases each year occur in

249 analyses of patients with EGFR FISH-positive squamous-cell carcinoma cancers are encouraging and supp

250 dissection in the treatment of patients with squamous-cell carcinoma of the head and neck who have ad

251 wly diagnosed, biopsy-proven stage III or IV squamous-cell carcinoma of the oropharynx, positive for

252 was recently proposed for advanced cutaneous squamous cell carcinomas (cSCC); however, its efficacy i

253 as (EACs) and EGFR overexpressing esophageal squamous cell carcinomas (ESCCs).

254 Head and neck squamous cell carcinomas (HNSCC) exhibiting resistance t

255 nome Atlas (TCGA) reveals that head and neck squamous cell carcinomas (HNSCC) harbor the most frequen

256 ed by stromal fibroblasts from head and neck squamous cell carcinomas (HNSCC).

257 papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are deadly and common

258 Head and neck squamous cell carcinomas (HNSCCs) are refractory to ther

259 owever, more recent studies of head and neck squamous cell carcinomas (HNSCCs) suggest that integrati

260 tures unique to human oral and oropharyngeal squamous cell carcinomas (OCSCC/OPSCC).

261 es an increasing proportion of oropharyngeal squamous cell carcinomas (OPSCCs), particularly in white

262 The associations were somewhat stronger in squamous cell carcinomas (SCC, OR = 4.90) than in urothe

263 Keratinocyte carcinomas (KCs), consisting of squamous cell carcinomas (SCCs) and basal cell carcinoma

264 Squamous cell carcinomas (SCCs) are heterogeneous tumors

265 multiple human papillomavirus (HPV)-positive squamous cell carcinomas (SCCs) arise.

266 Squamous cell carcinomas (SCCs) derived from interfollic

267 gs cooperate to act as a tumor suppressor in squamous cell carcinomas (SCCs).

268 as a predictive marker for HDACi response in squamous cell carcinomas and lymphomas, and unveiled let

269 Oral squamous cell carcinomas are a major cause of morbidity

270 Squamous cell carcinomas occurring at transition zones a

271 The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed

272 nt CRT regimens for both adenocarcinomas and squamous cell carcinomas of the esophagus.

273 Squamous cell carcinomas of the head and neck (SCCHN) af

274 Basal cell and squamous cell carcinomas of the skin are the commonest c

275 e establishes a chromatin state predisposing squamous cell carcinomas to undergo EMT and metastasis,

276 Using 313 adenocarcinomas and 138 squamous cell carcinomas with genetically supported ance

277 r tumors specimens (319 adenocarcinomas; 142 squamous cell carcinomas) were profiled from 245 black p

278 fty-six percent had adenocarcinomas, 34% had squamous cell carcinomas, and 10% had another histology.

279 which were frequently dysregulated in human squamous cell carcinomas, highlighting their potential a

280 al sources are lacking, such as in basal and squamous cell carcinomas, which are not included in nati

281 ed in national registries, such as basal and squamous cell carcinomas.

282 metimes with keratin pearls, consistent with squamous cell carcinomas.

283 ting toxicity in patients with head and neck squamous cell carcinomas.

284 ntigen for cancer diagnosis specifically for squamous cell carcinomas.

285 e (PI3Kalpha), are frequent in head and neck squamous cell carcinomas.

286 have recurrent copy-number variants in three squamous-cell carcinomas (oesophageal, head and neck and

287 atients who were EGFR FISH non-positive with squamous cell histology (HR 1.04, 95% CI 0.78-1.40; p=0.

288 Squamous cell histology was reported for 422 (28%) of 15

289 sis of EGFR FISH-positive subpopulation with squamous cell histology, overall survival was significan

290 -cell lung cancer (NSCLC), particularly with squamous cell histology.

291 -C is also associated with increased risk of squamous cell lung carcinoma in the International Lung C

292 65 patients with melanoma, lung nonsquamous, squamous cell lung or head and neck cancers who were tre

293 on at the MTD, patients with FGFR1-amplified squamous cell non-small-cell lung cancer (sqNSCLC; arm 1

294 Studies involving women with atypical squamous cells of undetermined significance (ASC-US) or

295 mal cytological findings; 1784 with atypical squamous cells of undetermined significance (ASCUS); 217

296 us (HPV) triage of cytology showing atypical squamous cells of undetermined significance (hereafter A

297 udy were patients with cT3,Nx,M0, esophageal squamous cell or adenocarcinoma and planned neoadjuvant

298 4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treat

299 because a small proportion can progress into squamous cell skin cancer.

300 This was driven by associations with squamous cell (SQ) carcinoma (OR = 1.45; P = 1.2 x 10(-3